Talk about 5G is everywhere right now, from the trade war with China to the ban on Huawei. Here's what 5G is and why it matters.Technologyread more
A federal judge in New York City on Wednesday said Deutsche Bank and Capital One can turn over financial documents related to President Donald Trump and his businesses in...Politicsread more
Shares of L Brands, the owner of Victoria's Secret and Bath & Body Works, rose nearly 11% in aftermarket trading Wednesday after the company reported it beat revenue and...Retailread more
CNEX, backed by Microsoft and Dell, filed new allegations in a Texas suit accusing China's Huawei and an executive of trade secrets theft.Technologyread more
Officials remained firmly committed to a "patient" policy stance at their meeting earlier this month.The Fedread more
A slew of retail earnings the past two weeks makes it clear that while Americans continue to shop, they aren't ringing registers at department stores.Retailread more
Stocks that would benefit from a federal infrastructure spending program fell after President Trump ended a meeting on infrastructure spending with Democratic leaders.Market Insiderread more
Controversial lawyer Michael Avenatti was indicted on charges of trying to extort athletic shoe giant Nike out of tens of millions of dollars by threatening to go public with...Politicsread more
Despite the president's claim that "you can't investigate and legislate simultaneously," certain must-pass pieces of legislation, including a debt ceiling hike, will...Politicsread more
Moody's said it's downgrading the outlook for Equifax from stable to negative, citing ongoing fallout from the company's 2018 data breach.Technologyread more
Amazon shareholders demanded the company to take action on a number of different issues during its annual shareholder meeting on Wednesday.Technologyread more
Eli Lilly plans to take a minority stake of its Elanco Animal Heath unit public, the pharmaceutical company said Tuesday.
Elanco's portfolio includes treatments for both livestock and pets.The decision comes after a strategic review of the business, which had weighed on Lilly's performance.
Lilly said it expects to offer a less than 20 percent stake in the new company in an initial public offering. Following the IPO, the company plans to divest its remaining ownership through a tax-efficient transaction.
Lilly share prices rose 4 percent Tuesday. At one point they were up nearly 6 percent, buoyed by the IPO plans and second-quarter earnings that were better than expected.
"Based on our strategic review, we concluded that after-tax value for Lilly shareholders would be maximized by pursuing an initial public offering of Elanco," Lilly CEO David Ricks said in a statement. "We believe this will allow Elanco to efficiently deploy its resources to those growth opportunities that best serve its customers. In addition, this will provide Lilly even greater focus on the human pharmaceutical business to pursue our purpose of creating life-changing medicines for patients."
Lilly expects to file a registration statement with the Securities and Exchange Commission in coming weeks and complete the IPO process in the second half of the year.
Correction: Eli Lilly plans to take public a less than 20 percent stake in its Elanco Animal Health unit. An earlier version incorrectly stated the company would hold a minority stake in the unit after the IPO.